Abbott Laboratories ABT:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 05/03/24 EDT

105.46

-0.44 (-0.42%)

Volume

346,186

105.90

-0.02 (-0.02%)

Volume

3,263,461

52 week range

89.67 - 121.64

Open106.11
Day High106.64
Day Low105.47
Prev Close105.92
52 Week High121.64
52 Week High Date03/08/24
52 Week Low89.67
52 Week Low Date10/12/23

Key Stats

Market Cap183.756B
Shares Out1.74B
10 Day Average Volume4.73M
Dividend2.20
Dividend Yield2.08%
Beta0.76
YTD % Change-3.79

KEY STATS

Open106.11
Day High106.64
Day Low105.47
Prev Close105.92
52 Week High121.64
52 Week High Date03/08/24
52 Week Low89.67
52 Week Low Date10/12/23
Market Cap183.756B
Shares Out1.74B
10 Day Average Volume4.73M
Dividend2.20
Dividend Yield2.08%
Beta0.76
YTD % Change-3.79

RATIOS/PROFITABILITY

EPS (TTM)3.22
P/E (TTM)32.89
Fwd P/E (NTM)23.05
EBITDA (TTM)9.592B
ROE (TTM)15.20%
Revenue (TTM)40.326B
Gross Margin (TTM)55.22%
Net Margin (TTM)13.96%
Debt To Equity (MRQ)38.03%

EVENTS

Earnings Date07/18/2024(est)
Ex Div Date04/12/2024
Div Amount0.55
Split Date-
Split Factor-

Latest On Abbott Laboratories

Jim Cramer's favorite investment themes in tough markets and 3 stocks he likes nowApril 25, 2024CNBC.com
A rapid-fire update on our 33 stocks including the tech giants reporting this weekApril 24, 2024CNBC.com
April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats upApril 24, 2024CNBC.com
Ford surges on Tesla's EV price cuts as legacy automaker falls back on its rootsApril 22, 2024CNBC.com
Jim Cramer's top 10 things to watch in the stock market MondayApril 22, 2024CNBC.com

Content From Our Affiliates

Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), Iterum Therapeutics (ITRM)April 30, 2024TipRanks
Abbott’s dissolving stent receives FDA approval for arteries below the kneeApril 29, 2024TipRanks
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?April 26, 2024TipRanks
3 Best Healthcare Stocks to Buy in April 2024, According to AnalystsApril 26, 2024TipRanks
Abbott price target lowered to $140 from $141 at BarclaysApril 22, 2024TipRanks

Profile

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The...

Robert Ford

Chairman of the Board, Chief Executive Officer

Philip Boudreau

Chief Financial Officer, Senior Vice President - Finance

Louis Morrone

Executive Vice President - Core Diagnostics

Daniel Salvadori

Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products

Hubert Allen

Executive Vice President, General Counsel, Secretary

Address

100 Abbott Park Road, Abbot Park

Abbott Park, IL

60064-3500

United States

https://www.abbott.com

Top Peers

SYMBOL	LAST	CHG	%CHG
TMO Thermo Fisher Scientific Inc	572.38	+1.13	+0.20%
DHR Danaher Corp	248.38	+1.54	+0.62%
MDT Medtronic PLC	81.69	+0.77	+0.95%
SYK Stryker Corp	328.45	+1.82	+0.56%
BSX Boston Scientific Corp	72.85	+0.82	+1.14%